Improving the Outcome of Patients With Heart Failure: Assessment of Iron Deficiency and Intravenous Iron Replacement

被引:2
作者
Yera, Hassan O. [1 ]
Khan, Ahsan [2 ]
Akinlade, Olawale M. [3 ]
Champsi, Asgher [2 ]
Glouzon, Van Nam J. [4 ]
Spencer, Charles [2 ]
机构
[1] Shrewsbury & Telford Hosp NHS Trust, Internal Med, Telford, England
[2] New Cross Hosp, Cardiol Heart & Lung Ctr, Wolverhampton, England
[3] Dumfries & Galloway Royal Infirm, Cardiol, Dumfries, Scotland
[4] New Cross Hosp, Internal Med Heart & Lung Ctr, Wolverhampton, England
关键词
morbidity and mortality; heart failure with reduced ejection fraction; quality improvement; ferric carboxymaltose; iron deficiency anaemia; REDUCED EJECTION FRACTION; FERRIC CARBOXYMALTOSE; EXERCISE CAPACITY; ANEMIA; SUBANALYSIS; PREVALENCE; THERAPY;
D O I
10.7759/cureus.47027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Iron deficiency (ID) has been shown to be a significant co-morbidity in patients with heart failure (HF), independent of their anaemia status. Correction of ID has been shown to improve quality of life, recurrent heart failure hospitalizations and morbidity. A quality improvement project was designed to improve the assessment and treatment of iron deficiency in HF patients in our tertiary care centre.Methods and results An initial baseline dataset was collected, followed by two cycles of interventions to help improve the care of HF patients admitted to our hospital over a two-month period. The Plan-Do-Study-Act (PDSA) cycle approach was applied, with the first intervention involving raising awareness of the importance and need to assess the iron status of HF patients through education provided to doctors, nurses and patients. Furthermore, information leaflets were produced and disseminated across the medical wards and through social media forums. The post-intervention datasets were collected and compared to the baseline outcomes. Baseline data showed that only four (20%) of heart failure patients had their iron status checked. Following the interventions, screening for ID increased to 80% (16), of which 85% (11) of those who identified as iron deficient received intravenous iron replacement.Conclusion The project was successful in improving the practice of screening for iron deficiency and intravenous replacement of iron in patients with HF.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Intravenous iron therapy among patients with heart failure and iron deficiency: An updated meta-analysis of randomized controlled trials
    Hamed, Mohamed
    Elseidy, Sheref A.
    Ahmed, Asmaa
    Thakker, Ravi
    Mansoor, Hend
    Khalili, Houman
    Mohsen, Amr
    Mamas, Mamas A.
    Banerjee, Subhash
    Kumbhani, Dharam J.
    Elgendy, Islam Y.
    Elbadawi, Ayman
    HELIYON, 2023, 9 (06)
  • [42] Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
    Ponikowski, Piotr
    van Veldhuisen, Dirk J.
    Comin-Colet, Josep
    Ertl, Georg
    Komajda, Michel
    Mareev, Viacheslav
    McDonagh, Theresa
    Parkhomenko, Alexander
    Tavazzi, Luigi
    Levesque, Victoria
    Mori, Claudio
    Roubert, Bernard
    Filippatos, Gerasimos
    Ruschitzka, Frank
    Anker, Stefan D.
    EUROPEAN HEART JOURNAL, 2015, 36 (11) : 657 - 668
  • [43] Effect of iron supplementation in patients with heart failure and iron deficiency: A systematic review and meta-analysis
    Yamani, Naser
    Ahmed, Aymen
    Gosain, Priyanka
    Fatima, Kaneez
    Shaikh, Ali Tariq
    Qamar, Humera
    Shahid, Izza
    Arshad, Muhammad Sameer
    Almas, Talal
    Figueredo, Vincent
    IJC HEART & VASCULATURE, 2021, 36
  • [44] Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials
    Bhatia, Kirtipal
    Sabharwal, Basera
    Gupta, Kartik
    Lopez, Persio D.
    Kaur, Arpanjeet
    Bhatia, Harsimran K.
    Gandhi, Kruti Dhaval
    Niroula, Shailesh
    Correa, Ashish
    Birati, Edo Y.
    Argulian, Edgar
    Fox, Arieh
    Mahmood, Kiran
    JOURNAL OF CARDIOLOGY, 2024, 83 (02) : 105 - 112
  • [45] Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials
    Mei, Ziwei
    Chen, Jun
    Luo, Songmei
    Jin, Lie
    Liu, Qiang
    Chen, Yijie
    PHARMACOLOGICAL RESEARCH, 2022, 182
  • [46] Anemia and iron deficiency in heart failure
    Gil, Victor M.
    Ferreira, Jorge S.
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2014, 33 (01) : 39 - 44
  • [47] The role of iron deficiency in heart failure
    Caminiti, Giuseppe
    Sposato, Barbara
    Volterrani, Maurizio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : C306 - C308
  • [48] Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron
    Toblli, Jorge E.
    Di Gennaro, Federico
    Rivas, Carlos
    HEART LUNG AND CIRCULATION, 2015, 24 (07) : 686 - 695
  • [49] Iron replacement therapy in heart failure: a literature review
    Ismahel, Hassan
    Ismahel, Nadeen
    EGYPTIAN HEART JOURNAL, 2021, 73 (01)
  • [50] Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
    Sindone, Andrew
    Doehner, Wolfram
    Manito, Nicolas
    McDonagh, Theresa
    Cohen-Solal, Alain
    Damy, Thibaud
    Nunez, Julio
    Pfister, Otmar
    van der Meer, Peter
    Comin-Colet, Josep
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)